Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism Ubiquitin ligase inhibitors(E3 ubiquitin ligase components inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationOrphan Drug (United States) |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colorectal Cancer | Phase 1 | United States | - | |
| Colorectal Cancer | Phase 1 | Taiwan Province | - | |
| Multiple Myeloma | Phase 1 | United States | - | |
| Multiple Myeloma | Phase 1 | Taiwan Province | - | |
| Non-Small Cell Lung Cancer | Phase 1 | United States | - | |
| Non-Small Cell Lung Cancer | Phase 1 | Taiwan Province | - | |
| Pancreatic Cancer | Phase 1 | United States | - | |
| Pancreatic Cancer | Phase 1 | Taiwan Province | - |





